Extracellular vesicle isolation, purification and evaluation in cancer diagnosis

Abstract

Strategies for non-invasive biomarker discovery in early detection of cancer are an urgent need. Extracellular vesicles (EVs) have generated increasing attention from the scientific community and are under intensive investigations due to their unique biological profiles and their non-invasive nature. EVs are membrane-enclosed vesicles with variable sizes and function. Such vesicles are actively secreted from multiple cell types and are considered as key vehicles for inter-cellular communications and signalling. The stability and potential to easily cross biological barriers enable EVs for exerting durable effects on target cells. These along with easy access to such vesicles, the consistent secretion from tumour during all stages of tumorigenesis and their content providing a reservoir of molecules as well as mirroring the identity of the cell of origin are virtues that have made EVs appealing to be assessed in liquid biopsy approaches and for using as a promising resource of biomarkers in cancer diagnosis and therapy and monitoring targeted cancer therapy. Early detection of EVs will guide time-scheduled personalised therapy. Surveying reliable and sensitive methods for rapid isolation of EVs from biofluids, the purity of isolated vesicles and their molecular profiling and marker specification for clinical translation in patients with cancer are issues in the area and the hot topics of many recent studies. Here, the focus is over methods for EV isolation and stratification for digging more information about liquid biopsy-based diagnosis. Extending knowledge regarding EV-based strategies is a key to validate independent patient follow-up for cancer diagnosis at early stages and inspecting the efficacy of therapeutics.

Anti-PD-(L)1 therapy of non-small cell lung cancer–A summary of clinical trials and current progresses

“…Their stability along with the potential to readily cross biological restrains has made such vesicles a desired target in cancer therapy. Easy access to such vesicles and their consistent release from all stages of tumorigenesis along with long-term storage of contents and their presence mirroring the identity of origin cell have all made EVs as effective targets in cancer therapy and a promising biomarker in cancer diagnosis and monitoring therapy responses [ 111 ]. In the future, we hear more about the importance of EVs in cancer immunity and immunotherapy.…”